MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Bihua Chen
Bihua ChenCORMORANT ASSET MANAGEMENT

Bihua Chen

CEO at CORMORANT ASSET MANAGEMENT

Investor

Deal Bio

Total Deals39
Valued Deals38
Total Value£ 5.22 B
Avg. Deal Size£ 137 M

Market Context

Sort

27 Apr 2020|United States|Biotechnology
ERASCA
Arch Venture Partners

Target: ERASCA

Bidder: ARCH VENTURE PARTNERS

10 Service Providers

3 Target | 7 Bidder

22 Dealmakers

8 Target | 14 Bidder

£ 161 M

Value

20 May 2020|United States|Pharmaceuticals
Atea Pharmaceuticals
Ally Bridge Group

Target: ATEA PHARMACEUTICALS INC

Bidder: ALLY BRIDGE GROUP

15 Service Providers

2 Target | 13 Bidder

27 Dealmakers

4 Target | 24 Bidder

£ 175 M

Value

16 Jun 2020|United States|Biotechnology
Greenlight Biosciences
Mls Capital Fund Ii

Target: GREENLIGHT BIOSCIENCES INC

Bidder: MLS CAPITAL FUND II

11 Service Providers

1 Target | 10 Bidder

12 Dealmakers

1 Target | 11 Bidder

£ 81 M

Value

04 Sep 2020|China|Pharmaceuticals
I-MAB
Hillhouse Capital Group

Target: I-MAB

Bidder: HILLHOUSE CAPITAL GROUP

18 Service Providers

6 Target | 12 Bidder

33 Dealmakers

8 Target | 25 Bidder

£ 315 M

Value

08 Jul 2020|United States|Biotechnology
Velosbio
Cormorant Asset Management

Target: VELOSBIO INC

Bidder: CORMORANT ASSET MANAGEMENT

14 Service Providers

2 Target | 12 Bidder

16 Dealmakers

2 Target | 14 Bidder

£ 105 M

Value

03 Mar 2020|United States|Medical Equipment
Element Science
The Invus Group

Target: ELEMENT SCIENCE INC

Bidder: THE INVUS GROUP LLC

10 Service Providers

3 Target | 7 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 114 M

Value

17 Jul 2020|United States|Pharmaceuticals
BIOATLA
Soleus Capital

Target: BIOATLA

Bidder: SOLEUS CAPITAL

10 Service Providers

2 Target | 8 Bidder

14 Dealmakers

6 Target | 8 Bidder

£ 55 M

Value

15 Oct 2020|Switzerland|Biotechnology
VECTIVBIO
Cormorant Asset Management

Target: VECTIVBIO

Bidder: CORMORANT ASSET MANAGEMENT

16 Service Providers

3 Target | 13 Bidder

35 Dealmakers

16 Target | 21 Bidder

£ 84 M

Value

28 Oct 2020|United States|Biotechnology
Miragen Therapeutics
VENROCK

Target: MIRAGEN THERAPEUTICS

Bidder: VENROCK

16 Service Providers

5 Target | 11 Bidder

19 Dealmakers

5 Target | 14 Bidder

£ 70 M

Value

16 Dec 2020|United States|Biotechnology
Neurogene
Casdin Capital

Target: NEUROGENE INC

Bidder: CASDIN CAPITAL

13 Service Providers

2 Target | 11 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 85 M

Value

11 Jan 2021|China|Pharmaceuticals
Visen Pharmaceuticals
Orbimed Pe

Target: VISEN PHARMACEUTICALS

Bidder: ORBIMED PE

12 Service Providers

1 Target | 11 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 111 M

Value

16 Feb 2021|United Kingdom|Pharmaceuticals
Centessa Pharmaceuticals
Janus Henderson Investors

Target: CENTESSA PHARMACEUTICALS

Bidder: JANUS HENDERSON INVESTORS

20 Service Providers

5 Target | 15 Bidder

27 Dealmakers

9 Target | 19 Bidder

£ 179 M

Value

26 Feb 2021|United States|Biotechnology
Artiva Biotherapeutics
Acuta Capital

Target: ARTIVA BIOTHERAPEUTICS

Bidder: ACUTA CAPITAL

16 Service Providers

3 Target | 13 Bidder

16 Dealmakers

3 Target | 13 Bidder

n/a

Value

22 Mar 2021|China|Biotechnology
Epimab Biotherapeutics
Octagon Investments

Target: EPIMAB BIOTHERAPEUTICS

Bidder: OCTAGON INVESTMENTS

12 Service Providers

2 Target | 10 Bidder

16 Dealmakers

6 Target | 10 Bidder

£ 86 M

Value

14 Apr 2021|United States|Biotechnology
Tango Therapeutics
Cormorant Asset Management

Target: TANGO THERAPEUTICS

Bidder: CORMORANT ASSET MANAGEMENT

29 Service Providers

5 Target | 24 Bidder

32 Dealmakers

15 Target | 19 Bidder

£ 257 M

Value

19 Mar 2021|United States|Medical Services
Icosavax
Sanofi Ventures

Target: ICOSAVAX INC

Bidder: SANOFI VENTURES

13 Service Providers

2 Target | 11 Bidder

19 Dealmakers

7 Target | 12 Bidder

£ 71 M

Value

12 Apr 2021|Ireland|Pharmaceuticals
Gh Research
Deerfield Management Company

Target: GH RESEARCH

Bidder: DEERFIELD MANAGEMENT COMPANY

10 Service Providers

10 Bidder

20 Dealmakers

20 Bidder

£ 91 M

Value

13 May 2021|China|Pharmaceuticals
Elpiscience Biopharmaceutical
Cormorant Asset Management

Target: ELPISCIENCE BIOPHARMACEUTICAL

Bidder: CORMORANT ASSET MANAGEMENT

10 Service Providers

1 Target | 9 Bidder

10 Dealmakers

1 Target | 9 Bidder

£ 74 M

Value

20 May 2021|Switzerland|Biotechnology
Numab Therapeutics
Novo Holdings

Target: NUMAB THERAPEUTICS

Bidder: NOVO HOLDINGS A/S

10 Service Providers

2 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 78 M

Value

26 May 2021|United States|Biotechnology
Nikang Therapeutics
Surveyor Capital

Target: NIKANG THERAPEUTICS

Bidder: SURVEYOR CAPITAL

23 Service Providers

2 Target | 21 Bidder

29 Dealmakers

5 Target | 24 Bidder

£ 141 M

Value

13 Jul 2021|United States|Biotechnology
Prime Medicine
T. Rowe Price Group

Target: PRIME MEDICINE

Bidder: T. ROWE PRICE GROUP INC

14 Service Providers

3 Target | 11 Bidder

17 Dealmakers

6 Target | 11 Bidder

£ 227 M

Value

15 Jun 2021|United States|Biotechnology
Umoja Biopharma
Cormorant Asset Management

Target: UMOJA BIOPHARMA

Bidder: CORMORANT ASSET MANAGEMENT

13 Service Providers

1 Target | 12 Bidder

14 Dealmakers

1 Target | 13 Bidder

£ 148 M

Value

28 Jul 2021|United States|Biotechnology
Strata Oncology
Baird Capital

Target: STRATA ONCOLOGY

Bidder: BAIRD CAPITAL

12 Service Providers

3 Target | 9 Bidder

11 Dealmakers

2 Target | 9 Bidder

£ 64 M

Value

10 Aug 2021|United States|Biotechnology
Greenlight Biosciences
Xeraya Capital

Target: GREENLIGHT BIOSCIENCES INC

Bidder: XERAYA CAPITAL

17 Service Providers

4 Target | 13 Bidder

39 Dealmakers

5 Target | 34 Bidder

£ 866 M

Value

20 Oct 2021|China|Pharmaceuticals
SHOUTI
Casdin Capital

Target: SHOUTI

Bidder: CASDIN CAPITAL

21 Service Providers

3 Target | 18 Bidder

20 Dealmakers

2 Target | 18 Bidder

£ 72 M

Value

17 Nov 2021|United States|Biotechnology
Chroma Medicine
Atlas Venture

Target: CHROMA MEDICINE

Bidder: ATLAS VENTURE LP

10 Service Providers

1 Target | 9 Bidder

12 Dealmakers

3 Target | 9 Bidder

£ 93 M

Value

04 Oct 2021|Switzerland|Biotechnology
Moonlake Immunotherapeutics
Bvf Partners

Target: MOONLAKE IMMUNOTHERAPEUTICS

Bidder: BVF PARTNERS

25 Service Providers

7 Target | 18 Bidder

44 Dealmakers

11 Target | 34 Bidder

£ 169 M

Value

05 Jan 2022|United States|Biotechnology
Korro Bio
Atlas Venture

Target: KORRO BIO

Bidder: ATLAS VENTURE LP

13 Service Providers

2 Target | 11 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 85 M

Value

09 Feb 2022|Canada|Pharmaceuticals
Ventus Therapeutics
Andreessen Horowitz (a16z)

Target: VENTUS THERAPEUTICS

Bidder: ANDREESSEN HOROWITZ LLC (A16Z)

12 Service Providers

3 Target | 9 Bidder

12 Dealmakers

2 Target | 10 Bidder

£ 103 M

Value

19 Apr 2022|United States|Biotechnology
Tessera Therapeutics
Abu Dhabi Investment Authority (adia)

Target: TESSERA THERAPEUTICS

Bidder: ABU DHABI INVESTMENT AUTHORITY (ADIA)

13 Service Providers

2 Target | 11 Bidder

26 Dealmakers

2 Target | 24 Bidder

£ 230 M

Value

10 May 2022|United States|Biotechnology
Moma Therapeutics
Rock Springs Capital

Target: MOMA THERAPEUTICS

Bidder: ROCK SPRINGS CAPITAL

15 Service Providers

2 Target | 13 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 121 M

Value

31 Aug 2022|United States|Medical Equipment
Jenavalve Technology
Gimv

Target: JENAVALVE TECHNOLOGY

Bidder: GIMV NV

9 Service Providers

2 Target | 7 Bidder

10 Dealmakers

2 Target | 8 Bidder

£ 85 M

Value

01 Mar 2023|United States|Biotechnology
Chroma Medicine
Arch Venture Partners

Target: CHROMA MEDICINE

Bidder: ARCH VENTURE PARTNERS

18 Service Providers

1 Target | 17 Bidder

18 Dealmakers

2 Target | 16 Bidder

£ 111 M

Value

05 Jan 2023|United States|Biotechnology
ENSOMA
Arix Bioscience

Target: ENSOMA

Bidder: ARIX BIOSCIENCE

19 Service Providers

3 Target | 16 Bidder

19 Dealmakers

3 Target | 16 Bidder

£ 108 M

Value

29 Mar 2023|United States|Medical Equipment
BIVACOR
Cormorant Asset Management

Target: BIVACOR

Bidder: CORMORANT ASSET MANAGEMENT

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 14 M

Value

23 May 2023|United States|Pharmaceuticals
Onkure Therapeutics
Surveyor Capital

Target: ONKURE THERAPEUTICS

Bidder: SURVEYOR CAPITAL

11 Service Providers

1 Target | 10 Bidder

15 Dealmakers

2 Target | 13 Bidder

£ 43 M

Value

21 May 2024|United States|Pharmaceuticals
ALTRUBIO
Bvf Partners

Target: ALTRUBIO

Bidder: BVF PARTNERS

11 Service Providers

3 Target | 8 Bidder

10 Dealmakers

2 Target | 8 Bidder

£ 177 M

Value

23 Jul 2024|United States|Biotechnology
Third Arc Bio
Vida Ventures

Target: THIRD ARC BIO

Bidder: VIDA VENTURES

15 Service Providers

1 Target | 14 Bidder

14 Dealmakers

1 Target | 13 Bidder

£ 127 M

Value

03 Dec 2021|United States|Online and Social Platforms
CONNECTRN
Suvretta Capital

Target: CONNECTRN

Bidder: SUVRETTA CAPITAL

10 Service Providers

1 Target | 9 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 22 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Bihua Chen